Searchable abstracts of presentations at key conferences in endocrinology

ea0035p278 | Clinical case reports Thyroid/Others | ECE2014

Giant mediastinal parathyroid cyst with hyperparathyroidism: a case report

Gabalec Filip , Svilias Ioannis , Hornychova Helena , Habal Petr , Cap Jan

Primary hyperparathyroidism (PHPT) is rarely caused by parathyroid adenoma with cystic degeneration, especially by the cyst localized in mediastinum. Both differential diagnosis of mediastinal cyst and management of the patient can be challenging.Case presentation: A 57 years old woman was transferred from district hospital where her urosepsis and nephrolithiasis had been treated successfully. A liquid collection in left hemithorax had also been found du...

ea0070aep450 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Congenital anomaly of the kidney and urinary tract and mody 5 due to 17Q12 deletion syndrome; a case report

Siolos Athanasios , Merkoviti Maria , Georgiou Ioannis , Siomou Ekaterini , Tigas Stelios

Hepatocyte nuclear factor 1B (HNF1B) defects (mutations or deletion) are associated with amultisystem disorder, including urinary tract abnormalities and diabetes (MODY 5, maturity-onset diabetes of the young type 5). We present the case of a patient with congenital anomalies of the kidney and urinary tract in the context of 17q12 deletion syndrome who several years later, presented with MODY 5. A 20-year-old male presented at the outpatient Endocrine Clinic with new-...

ea0026p123 | Female reproduction | ECE2011

Self-reported health related quality of life and depression in women with polycystic ovary syndrome: associations with selected metabolic and hormonal PCOS features.

Vrbikova Jana , Hill Martin , Vankova Marketa , Kyrou Ioannis

Introduction: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age causing symptoms that can lead to depression and reduced health-related quality of life (HRQoL). Associations of depression and HRQoL indices with hormonal and metabolic PCOS features have not been adequately studied.Methods/design: Thirty-seven premenopausal women (age: 28±6.4 years; BMI: 28.3±7.2 kg/m2) with PCOS accord...

ea0022p289 | Diabetes | ECE2010

Association of diabetes mellitus with thalassaemia and sickle cell disease

Thisiadou Katerina , Karamouzis Ioannis , Arampatzi Stella , Tomos Kostantinos , Michailidou Despoina

Background: The majority of complications in transfusion dependent thallasemic and with sickle cell anemia patients are due to iron overload. This is responsible for the beginning of haemosiderosis, clinical symptoms and dysfunction of important systems, specially after the 2nd decade of life. The increase of the iron accumulation is caused by hemolysis, high iron absorbance and mainly by transfusion treatment. The appearance of diabetes mellitus depends on the significance an...

ea0022p291 | Diabetes | ECE2010

Coagulation inhibitors in type 2 diabetes mellitus

Thisiadou Katerina , Karamouzis Ioannis , Arampatzi Stella , Lazaridou Despoina

Background: Diabetes mellitus (DM) is related to hypercoagulability.The predisposition for thrombosis disorders is caused by increased accumulation of platelets, by high concentrations of prothrombotic factors and by the reduced concentration and activity of the inhibitor factors. Abnormalities of coagulation inhibitors have been reported in many studies on diabetes over the last years, but unfortunately, the results have often appeared contradictory.</p...

ea0020p362 | Diabetes and Cardiovascular | ECE2009

Klotho gene polymorphism may be a genetic risk factor for metabolic syndrome in men

Katsoulis Constantinos , Chatzikyriakidou Anthi , Xita Nektaria , Georgiou Ioannis , Tsatsoulis Agathocles

Introduction: Klotho has an important role in insulin signaling and the development of ageing-like phenotypes in mice. Recently, the G-395A polymorphism in the promoter region of the human klotho gene has been reported to affect promoter function. It has been also shown to be an independent genetic risk factor for atherosclerotic cardiovascular disease. The aim of this study was to examine the possible role of this polymorphism in the metabolic syndrome....

ea0016p106 | Clinical cases | ECE2008

Coexistance of parathyroid tumors with metachronous metastasis to the thyroid from renal clear cell carcinoma 20 years after nephrectomy

Legakis Ioannis , Koutsoupa Kaliopi , Doundoulakis George , Alamani Maria , Kyrodimou Efi

We report a rare case of a solitary metachronus metastasis of renal clear cell carcinoma (RCC) in the thyroid coexisting with parathyroid tumors. The patient had undergone 20 years ago radical left nephrectomy for RCC. Upon presentation, the initial diagnosis based on clinical and echo findings was multinodular goiter. Fine needle aspiration (FNA) cytology of a growing non-functioning nodule of the right thyroid lobe revealed clear cells with oxyphilic granules suggesting RCC....

ea0014p263 | (1) | ECE2007

The importance of (TAAAA)n polymorphism of SHBG gene in the metabolic syndrome

Xita Nektaria , Milionis Charalambos , Georgiou Ioannis , Elisaf Moses , Tsatsoulis Agathocles

Introduction: Sex hormone binding globulin (SHBG) levels have been associated with the development of the metabolic syndrome. In particular, low SHBG levels have been proposed as an indicator of increased risk for metabolic syndrome in men. The (TAAAA)n repeat polymorphism SHBG gene is believed to affect SHBG levels. In vitro experiments have shown that the allele with 6 TAAAA repeats is associated with decreased transcriptional activity of SHBG gene. The aim of this study was...

ea0014p342 | (1) | ECE2007

“False negative” results of Tg in patients with DTC (differentiated thyroid carcinoma)

Voliotopoulos Vassilios , Gianakopoulos Vassilios , Valais Ioannis , Charalabidou Isaia

Purpose: The long-term monitoring of patients with differentiated thyroid carcinoma is essential throughout the patient’s life after total or near total thyroidectomy followed by I-131 ablation after thyroid suppression using recombinant TSH (Thyrogen).As known the administration of rhTSH increase the sensitivity of Tg concentrations measurements. Antithyroglobulin antibodies are common clinical problem in patients with differentiated thyroid carcin...

ea0056p106 | Clinical case reports - Pituitary/Adrenal | ECE2018

Cushing’s syndrome in a patient with systemic lupus erythematosus

Kostoglou-Athanassiou Ifigenia , Spiliotis George , Athanassiou Lambros , Myriokefalitakis Ioannis

Introduction: Systemic lupus erythematosus is a systemic autoimmune disease, which often necessitates the administration of corticosteroids for its treatment. Cushing’s syndrome is a disorder characterized by the endogenous hypersecretion of cortisol.Aim: The aim was to describe the case of a patient who had systemic lupus erythematosus, was on therapy with corticosteroids and developed Cushing’s syndrome.Case description...